{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T01:01:16Z","timestamp":1792112476348,"version":"4.4.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T00:00:00Z","timestamp":1754611200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T00:00:00Z","timestamp":1754611200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Drugs Ther"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s10557-025-07740-y","type":"journal-article","created":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T08:32:14Z","timestamp":1754641934000},"page":"1107-1116","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The Relationship and Mechanism of CD27 with Coronary Atherosclerotic Heart Disease"],"prefix":"10.1007","volume":"40","author":[{"given":"Xue Fei","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0130-9985","authenticated-orcid":false,"given":"Fei","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi Gang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo An","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si Yu","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Pu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,8]]},"reference":[{"key":"7740_CR1","doi-asserted-by":"publisher","first-page":"1296668","DOI":"10.3389\/fimmu.2023.1296668","volume":"14","author":"T Pattarabanjird","year":"2023","unstructured":"Pattarabanjird T, Srikakulapu P, Ransegnola B, et al. Single-cell profiling of CD11c+ B cells in atherosclerosis. Front Immunol. 2023;14:1296668. https:\/\/doi.org\/10.3389\/fimmu.2023.1296668.","journal-title":"Front Immunol"},{"key":"7740_CR2","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.3389\/fimmu.2018.02031","volume":"9","author":"M Fioranelli","year":"2018","unstructured":"Fioranelli M, Bottaccioli AG, Bottaccioli F, et al. Stress and inflammation in coronary artery disease: a review psychoneuroendocrineimmunology-based. Front Immunol. 2018;9:2031. https:\/\/doi.org\/10.3389\/fimmu.2018.02031.","journal-title":"Front Immunol"},{"issue":"1","key":"7740_CR3","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1093\/cvr\/cvn248","volume":"81","author":"IE Dumitriu","year":"2009","unstructured":"Dumitriu IE, Aragu\u00e1s ET, Baboonian C, Kaski JC. CD4+ CD28 null T cells in coronary artery disease: when helpers become killers. Cardiovasc Res. 2009;81(1):11\u20139. https:\/\/doi.org\/10.1093\/cvr\/cvn248.","journal-title":"Cardiovasc Res"},{"issue":"1","key":"7740_CR4","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1111\/joim.13557","volume":"293","author":"J Frosteg\u00e5rd","year":"2023","unstructured":"Frosteg\u00e5rd J. Systemic lupus erythematosus and cardiovascular disease. J Intern Med. 2023;293(1):48\u201362. https:\/\/doi.org\/10.1111\/joim.13557.","journal-title":"J Intern Med"},{"issue":"4","key":"7740_CR5","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.cjca.2018.01.015","volume":"34","author":"RD Kurmann","year":"2018","unstructured":"Kurmann RD, Mankad R. Atherosclerotic heart disease in women with autoimmune rheumatologic inflammatory conditions. Can J Cardiol. 2018;34(4):381\u20139. https:\/\/doi.org\/10.1016\/j.cjca.2018.01.015.","journal-title":"Can J Cardiol"},{"issue":"6","key":"7740_CR6","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.jacc.2021.11.048","volume":"79","author":"JT Vuong","year":"2022","unstructured":"Vuong JT, Stein-Merlob AF, Nayeri A, et al. Immune checkpoint therapies and atherosclerosis: mechanisms and clinical implications: JACC state-of-the-art review. J Am Coll Cardiol. 2022;79(6):577\u201393. https:\/\/doi.org\/10.1016\/j.jacc.2021.11.048.","journal-title":"J Am Coll Cardiol"},{"key":"7740_CR7","doi-asserted-by":"publisher","unstructured":"Trigka M, Dritsas E. Long-term coronary artery disease risk prediction with machine learning models. Sensors (Basel). 2023;23(3). https:\/\/doi.org\/10.3390\/s23031193.","DOI":"10.3390\/s23031193"},{"issue":"4","key":"7740_CR8","doi-asserted-by":"publisher","first-page":"257","DOI":"10.2174\/187152910793743832","volume":"10","author":"S Negi","year":"2010","unstructured":"Negi S, Anand A. Atherosclerotic coronary heart disease-epidemiology, classification and management. Cardiovasc Hematol Disord Drug Targets. 2010;10(4):257\u201361. https:\/\/doi.org\/10.2174\/187152910793743832.","journal-title":"Cardiovasc Hematol Disord Drug Targets"},{"issue":"6","key":"7740_CR9","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.jacbts.2021.01.006","volume":"6","author":"T Pattarabanjird","year":"2021","unstructured":"Pattarabanjird T, Li C, McNamara C. B cells in atherosclerosis: mechanisms and potential clinical applications. JACC Basic Transl Sci. 2021;6(6):546\u201363. https:\/\/doi.org\/10.1016\/j.jacbts.2021.01.006.","journal-title":"JACC Basic Transl Sci"},{"issue":"1","key":"7740_CR10","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1186\/s12933-022-01656-9","volume":"21","author":"KB Won","year":"2022","unstructured":"Won KB, Lee BK, Lin FY, et al. Glycemic control is independently associated with rapid progression of coronary atherosclerosis in the absence of a baseline coronary plaque burden: a retrospective case-control study from the PARADIGM registry. Cardiovasc Diabetol. 2022;21(1):239. https:\/\/doi.org\/10.1186\/s12933-022-01656-9.","journal-title":"Cardiovasc Diabetol"},{"issue":"12","key":"7740_CR11","doi-asserted-by":"publisher","first-page":"2653","DOI":"10.1016\/j.jcmg.2020.01.006","volume":"13","author":"R Hajhosseiny","year":"2020","unstructured":"Hajhosseiny R, Bustin A, Munoz C, et al. Coronary magnetic resonance angiography: technical innovations leading us to the promised land? JACC Cardiovasc Imaging. 2020;13(12):2653\u201372. https:\/\/doi.org\/10.1016\/j.jcmg.2020.01.006.","journal-title":"JACC Cardiovasc Imaging"},{"issue":"6","key":"7740_CR12","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1016\/j.immuni.2013.06.009","volume":"38","author":"P Libby","year":"2013","unstructured":"Libby P, Lichtman AH, Hansson GK. Immune effector mechanisms implicated in atherosclerosis: from mice to humans. Immunity. 2013;38(6):1092\u2013104. https:\/\/doi.org\/10.1016\/j.immuni.2013.06.009.","journal-title":"Immunity"},{"key":"7740_CR13","doi-asserted-by":"publisher","first-page":"876616","DOI":"10.3389\/fimmu.2022.876616","volume":"13","author":"S Zhao","year":"2022","unstructured":"Zhao S, Wu Y, Wei Y, Xu X, Zheng J. Identification of biomarkers associated with CD8+ T cells in coronary artery disease and their pan-cancer analysis. Front Immunol. 2022;13:876616. https:\/\/doi.org\/10.3389\/fimmu.2022.876616.","journal-title":"Front Immunol"},{"key":"7740_CR14","doi-asserted-by":"publisher","first-page":"900334","DOI":"10.3389\/fimmu.2022.900334","volume":"13","author":"Y Li","year":"2022","unstructured":"Li Y, Jiang S, Li J, et al. Phenotypic changes of peripheral \u03b3\u03b4 T cell and its subsets in patients with coronary artery disease. Front Immunol. 2022;13:900334. https:\/\/doi.org\/10.3389\/fimmu.2022.900334.","journal-title":"Front Immunol"},{"key":"7740_CR15","doi-asserted-by":"publisher","first-page":"843712","DOI":"10.3389\/fimmu.2022.843712","volume":"13","author":"H Li","year":"2022","unstructured":"Li H, Cao Z, Wang L, et al. Macrophage subsets and death are responsible for atherosclerotic plaque formation. Front Immunol. 2022;13:843712. https:\/\/doi.org\/10.3389\/fimmu.2022.843712.","journal-title":"Front Immunol"},{"key":"7740_CR16","doi-asserted-by":"publisher","first-page":"682853","DOI":"10.3389\/fimmu.2021.682853","volume":"12","author":"X Feng","year":"2021","unstructured":"Feng X, Chen W, Ni X, et al. Metformin. Front Immunol. 2021;12:682853. https:\/\/doi.org\/10.3389\/fimmu.2021.682853.","journal-title":"Front Immunol"},{"issue":"7","key":"7740_CR17","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1161\/circresaha.121.320436","volume":"130","author":"T Pattarabanjird","year":"2022","unstructured":"Pattarabanjird T, Marshall M, Upadhye A, et al. B-1b cells possess unique bHLH-driven P62-dependent self-renewal and atheroprotection. Circ Res. 2022;130(7):981\u201393. https:\/\/doi.org\/10.1161\/circresaha.121.320436.","journal-title":"Circ Res"},{"issue":"10","key":"7740_CR18","doi-asserted-by":"publisher","first-page":"e55","DOI":"10.1161\/circresaha.119.315786","volume":"125","author":"A Upadhye","year":"2019","unstructured":"Upadhye A, Srikakulapu P, Gonen A, et al. Diversification and CXCR4-dependent establishment of the bone marrow B-1a cell pool governs atheroprotective IgM production linked to human coronary atherosclerosis. Circ Res. 2019;125(10):e55\u201370. https:\/\/doi.org\/10.1161\/circresaha.119.315786.","journal-title":"Circ Res"},{"issue":"3","key":"7740_CR19","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1161\/circresaha.120.316903","volume":"127","author":"A Zernecke","year":"2020","unstructured":"Zernecke A, Winkels H, Cochain C, et al. Meta-analysis of leukocyte diversity in atherosclerotic mouse aortas. Circ Res. 2020;127(3):402\u201326. https:\/\/doi.org\/10.1161\/circresaha.120.316903.","journal-title":"Circ Res"},{"issue":"9","key":"7740_CR20","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1161\/circulationaha.112.001347","volume":"127","author":"T Kyaw","year":"2013","unstructured":"Kyaw T, Winship A, Tay C, et al. Cytotoxic and proinflammatory CD8+ T lymphocytes promote development of vulnerable atherosclerotic plaques in apoE-deficient mice. Circulation. 2013;127(9):1028\u201339. https:\/\/doi.org\/10.1161\/circulationaha.112.001347.","journal-title":"Circulation"},{"issue":"3","key":"7740_CR21","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1161\/circresaha.117.304611","volume":"117","author":"C Cochain","year":"2015","unstructured":"Cochain C, Koch M, Chaudhari SM, et al. CD8+ T cells regulate monopoiesis and circulating Ly6C-high monocyte levels in atherosclerosis in mice. Circ Res. 2015;117(3):244\u201353. https:\/\/doi.org\/10.1161\/circresaha.117.304611.","journal-title":"Circ Res"},{"issue":"1","key":"7740_CR22","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1111\/imr.13073","volume":"308","author":"SJ Zhao","year":"2022","unstructured":"Zhao SJ, Muyayalo KP, Luo J, et al. Next generation of immune checkpoint molecules in maternal-fetal immunity. Immunol Rev. 2022;308(1):40\u201354. https:\/\/doi.org\/10.1111\/imr.13073.","journal-title":"Immunol Rev"},{"issue":"3","key":"7740_CR23","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.cell.2022.01.008","volume":"185","author":"G Morad","year":"2022","unstructured":"Morad G, Helmink BA, Sharma P, Wargo JA. Hallmarks of response, resistance, and toxicity to immune checkpoint blockade. Cell. 2022;185(3):576. https:\/\/doi.org\/10.1016\/j.cell.2022.01.008.","journal-title":"Cell"},{"key":"7740_CR24","doi-asserted-by":"publisher","first-page":"887916","DOI":"10.3389\/fimmu.2022.887916","volume":"13","author":"Q Wang","year":"2022","unstructured":"Wang Q, He Y, Li W, et al. Soluble immune checkpoint-related proteins in blood are associated with invasion and progression in non-small cell lung cancer. Front Immunol. 2022;13:887916. https:\/\/doi.org\/10.3389\/fimmu.2022.887916.","journal-title":"Front Immunol"},{"issue":"8","key":"7740_CR25","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1038\/s41423-020-0488-6","volume":"17","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Zhang Z. The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications. Cell Mol Immunol. 2020;17(8):807\u201321. https:\/\/doi.org\/10.1038\/s41423-020-0488-6.","journal-title":"Cell Mol Immunol"},{"issue":"3","key":"7740_CR26","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/s41573-018-0006-z","volume":"18","author":"RS Riley","year":"2019","unstructured":"Riley RS, June CH, Langer R, Mitchell MJ. Delivery technologies for cancer immunotherapy. Nat Rev Drug Discov. 2019;18(3):175\u201396. https:\/\/doi.org\/10.1038\/s41573-018-0006-z.","journal-title":"Nat Rev Drug Discov"},{"issue":"2","key":"7740_CR27","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.imlet.2011.01.008","volume":"136","author":"S Libregts","year":"2011","unstructured":"Libregts S, van Olffen RW, van der Sluijs KF, van Lier RA, Nolte MA. Function of CD27 in helper T cell differentiation. Immunol Lett. 2011;136(2):177\u201386. https:\/\/doi.org\/10.1016\/j.imlet.2011.01.008.","journal-title":"Immunol Lett"},{"issue":"6","key":"7740_CR28","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1093\/intimm\/dxm033","volume":"19","author":"MF van Oosterwijk","year":"2007","unstructured":"van Oosterwijk MF, Juwana H, Arens R, et al. CD27-CD70 interactions sensitise naive CD4+ T cells for IL-12-induced Th1 cell development. Int Immunol. 2007;19(6):713\u20138. https:\/\/doi.org\/10.1093\/intimm\/dxm033.","journal-title":"Int Immunol"},{"issue":"2","key":"7740_CR29","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.immuni.2024.01.011","volume":"57","author":"CA Jaeger-Ruckstuhl","year":"2024","unstructured":"Jaeger-Ruckstuhl CA, Lo Y, Fulton E, et al. Signaling via a CD27-TRAF2-SHP-1 axis during naive T cell activation promotes memory-associated gene regulatory networks. Immunity. 2024;57(2):287-302.e12. https:\/\/doi.org\/10.1016\/j.immuni.2024.01.011.","journal-title":"Immunity"},{"issue":"3","key":"7740_CR30","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.coi.2005.04.004","volume":"17","author":"J Borst","year":"2005","unstructured":"Borst J, Hendriks J, Xiao Y. CD27 and CD70 in T cell and B cell activation. Curr Opin Immunol. 2005;17(3):275\u201381. https:\/\/doi.org\/10.1016\/j.coi.2005.04.004.","journal-title":"Curr Opin Immunol"},{"key":"7740_CR31","doi-asserted-by":"publisher","first-page":"107709","DOI":"10.1016\/j.pharmthera.2020.107709","volume":"219","author":"T Tang","year":"2021","unstructured":"Tang T, Cheng X, Truong B, et al. Molecular basis and therapeutic implications of CD40\/CD40L immune checkpoint. Pharmacol Ther. 2021;219:107709. https:\/\/doi.org\/10.1016\/j.pharmthera.2020.107709.","journal-title":"Pharmacol Ther"},{"issue":"1","key":"7740_CR32","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1111\/j.1600-065X.2009.00782.x","volume":"229","author":"R Elgueta","year":"2009","unstructured":"Elgueta R, Benson MJ, de Vries VC, et al. Molecular mechanism and function of CD40\/CD40L engagement in the immune system. Immunol Rev. 2009;229(1):152\u201372. https:\/\/doi.org\/10.1111\/j.1600-065X.2009.00782.x.","journal-title":"Immunol Rev"},{"key":"7740_CR33","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.addr.2018.12.005","volume":"141","author":"JL Karnell","year":"2019","unstructured":"Karnell JL, Rieder SA, Ettinger R, Kolbeck R. Targeting the CD40-CD40L pathway in autoimmune diseases: humoral immunity and beyond. Adv Drug Deliv Rev. 2019;141:92\u2013103. https:\/\/doi.org\/10.1016\/j.addr.2018.12.005.","journal-title":"Adv Drug Deliv Rev"},{"issue":"6","key":"7740_CR34","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1161\/atvbaha.115.306983","volume":"36","author":"P Srikakulapu","year":"2016","unstructured":"Srikakulapu P, Hu D, Yin C, et al. Artery tertiary lymphoid organs control multilayered territorialized atherosclerosis B-cell responses in aged ApoE-\/- mice. Arterioscler Thromb Vasc Biol. 2016;36(6):1174\u201385. https:\/\/doi.org\/10.1161\/atvbaha.115.306983.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"15","key":"7740_CR35","doi-asserted-by":"publisher","first-page":"2508","DOI":"10.1093\/cvr\/cvad099","volume":"119","author":"V Smit","year":"2023","unstructured":"Smit V, de Mol J, Schaftenaar FH, et al. Single-cell profiling reveals age-associated immunity in atherosclerosis. Cardiovasc Res. 2023;119(15):2508\u201321. https:\/\/doi.org\/10.1093\/cvr\/cvad099.","journal-title":"Cardiovasc Res"},{"key":"7740_CR36","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.coviro.2016.12.001","volume":"22","author":"EJ Grant","year":"2017","unstructured":"Grant EJ, N\u00fcssing S, Sant S, Clemens EB, Kedzierska K. The role of CD27 in anti-viral T-cell immunity. Curr Opin Virol. 2017;22:77\u201388. https:\/\/doi.org\/10.1016\/j.coviro.2016.12.001.","journal-title":"Curr Opin Virol"},{"issue":"2","key":"7740_CR37","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1093\/cei\/uxac114","volume":"213","author":"O Grimsholm","year":"2023","unstructured":"Grimsholm O. CD27 on human memory B cells-more than just a surface marker. Clin Exp Immunol. 2023;213(2):164\u201372. https:\/\/doi.org\/10.1093\/cei\/uxac114.","journal-title":"Clin Exp Immunol"},{"issue":"1","key":"7740_CR38","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1038\/s41467-023-37614-6","volume":"14","author":"L Gong","year":"2023","unstructured":"Gong L, Luo J, Zhang Y, et al. Nasopharyngeal carcinoma cells promote regulatory T cell development and suppressive activity via CD70-CD27 interaction. Nat Commun. 2023;14(1):1912. https:\/\/doi.org\/10.1038\/s41467-023-37614-6.","journal-title":"Nat Commun"},{"issue":"1","key":"7740_CR39","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1182\/blood-2017-07-741025","volume":"131","author":"SL Buchan","year":"2018","unstructured":"Buchan SL, Rogel A, Al-Shamkhani A. The immunobiology of CD27 and OX40 and their potential as targets for cancer immunotherapy. Blood. 2018;131(1):39\u201348. https:\/\/doi.org\/10.1182\/blood-2017-07-741025.","journal-title":"Blood"},{"issue":"Suppl 3","key":"7740_CR40","doi-asserted-by":"publisher","first-page":"e000629","DOI":"10.1136\/esmoopen-2019-000629","volume":"4","author":"AM Starzer","year":"2020","unstructured":"Starzer AM, Berghoff AS. New emerging targets in cancer immunotherapy: CD27 (TNFRSF7). ESMO Open. 2020;4(Suppl 3):e000629. https:\/\/doi.org\/10.1136\/esmoopen-2019-000629.","journal-title":"ESMO Open"},{"key":"7740_CR41","doi-asserted-by":"publisher","first-page":"81","DOI":"10.3389\/fimmu.2011.00081","volume":"2","author":"YC Wu","year":"2011","unstructured":"Wu YC, Kipling D, Dunn-Walters DK. The relationship between CD27 negative and positive B cell populations in human peripheral blood. Front Immunol. 2011;2:81. https:\/\/doi.org\/10.3389\/fimmu.2011.00081.","journal-title":"Front Immunol"},{"issue":"1","key":"7740_CR42","doi-asserted-by":"publisher","first-page":"149","DOI":"10.4049\/jimmunol.155.1.149","volume":"155","author":"C Tortorella","year":"1995","unstructured":"Tortorella C, Schulze-Koops H, Thomas R, et al. Expression of CD45RB and CD27 identifies subsets of CD4+ memory T cells with different capacities to induce B cell differentiation. J Immunol. 1995;155(1):149\u201362.","journal-title":"J Immunol"},{"key":"7740_CR43","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.ijcard.2018.11.132","volume":"278","author":"W Li","year":"2019","unstructured":"Li W, Zhang F, Ju C, Lv S, Huang K. The role of CD27-CD70 signaling in myocardial infarction and cardiac remodeling. Int J Cardiol. 2019;278:210\u20136. https:\/\/doi.org\/10.1016\/j.ijcard.2018.11.132.","journal-title":"Int J Cardiol"},{"issue":"48","key":"7740_CR44","doi-asserted-by":"publisher","first-page":"3590","DOI":"10.1093\/eurheartj\/ehx517","volume":"38","author":"H Winkels","year":"2017","unstructured":"Winkels H, Meiler S, Lievens D, et al. CD27 co-stimulation increases the abundance of regulatory T cells and reduces atherosclerosis in hyperlipidaemic mice. Eur Heart J. 2017;38(48):3590\u20139. https:\/\/doi.org\/10.1093\/eurheartj\/ehx517.","journal-title":"Eur Heart J"},{"issue":"1","key":"7740_CR45","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1186\/s12885-024-11945-z","volume":"24","author":"X Wang","year":"2024","unstructured":"Wang X, Luo K, Xu Q, et al. Prognostic marker CD27 and its micro-environmental in multiple myeloma. BMC Cancer. 2024;24(1):352. https:\/\/doi.org\/10.1186\/s12885-024-11945-z.","journal-title":"BMC Cancer"},{"issue":"21","key":"7740_CR46","doi-asserted-by":"publisher","first-page":"13353","DOI":"10.1074\/jbc.273.21.13353","volume":"273","author":"H Akiba","year":"1998","unstructured":"Akiba H, Nakano H, Nishinaka S, et al. CD27, a member of the tumor necrosis factor receptor superfamily, activates NF-kappaB and stress-activated protein kinase\/c-Jun N-terminal kinase via TRAF2, TRAF5, and NF-kappaB-inducing kinase. J Biol Chem. 1998;273(21):13353\u20138. https:\/\/doi.org\/10.1074\/jbc.273.21.13353.","journal-title":"J Biol Chem"},{"issue":"5","key":"7740_CR47","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1080\/21645515.2019.1571892","volume":"15","author":"Y Jiang","year":"2019","unstructured":"Jiang Y, Chen M, Nie H, Yuan Y. PD-1 and PD-L1 in cancer immunotherapy: clinical implications and future considerations. Hum Vaccin Immunother. 2019;15(5):1111\u201322. https:\/\/doi.org\/10.1080\/21645515.2019.1571892.","journal-title":"Hum Vaccin Immunother"},{"issue":"2","key":"7740_CR48","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.jaci.2020.12.654","volume":"148","author":"T Hirano","year":"2021","unstructured":"Hirano T, Honda T, Kanameishi S, et al. PD-L1 on mast cells suppresses effector CD8(+) T-cell activation in the skin in murine contact hypersensitivity. J Allergy Clin Immunol. 2021;148(2):563-73.e7. https:\/\/doi.org\/10.1016\/j.jaci.2020.12.654.","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"7740_CR49","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1189\/jlb.3MA0717-283","volume":"103","author":"CM Weyand","year":"2018","unstructured":"Weyand CM, Berry GJ, Goronzy JJ. The immunoinhibitory PD-1\/PD-L1 pathway in inflammatory blood vessel disease. J Leukoc Biol. 2018;103(3):565\u201375. https:\/\/doi.org\/10.1189\/jlb.3MA0717-283.","journal-title":"J Leukoc Biol"},{"key":"7740_CR50","doi-asserted-by":"publisher","unstructured":"Veluswamy P, Wacker M, Scherner M, Wippermann J. Delicate role of PD-L1\/PD-1 axis in blood vessel inflammatory diseases: current insight and future significance. Int J Mol Sci. 2020;21(21). https:\/\/doi.org\/10.3390\/ijms21218159.","DOI":"10.3390\/ijms21218159"},{"key":"7740_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijcard.2021.11.060","volume":"349","author":"K Fujisue","year":"2022","unstructured":"Fujisue K, Yamamoto E, Sueta D, et al. Increased soluble programed cell death-ligand 1 is associated with acute coronary syndrome. Int J Cardiol. 2022;349:1\u20136. https:\/\/doi.org\/10.1016\/j.ijcard.2021.11.060.","journal-title":"Int J Cardiol"},{"issue":"9","key":"7740_CR52","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1038\/s12276-021-00670-3","volume":"53","author":"F Du","year":"2021","unstructured":"Du F, Qi X, Zhang A, et al. MRTF-A-NF-\u03baB\/p65 axis-mediated PDL1 transcription and expression contributes to immune evasion of non-small-cell lung cancer via TGF-\u03b2. Exp Mol Med. 2021;53(9):1366\u201378. https:\/\/doi.org\/10.1038\/s12276-021-00670-3.","journal-title":"Exp Mol Med"},{"issue":"1","key":"7740_CR53","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s40959-021-00106-x","volume":"7","author":"JC Lal","year":"2021","unstructured":"Lal JC, Brown SA, Collier P, Cheng F. A retrospective analysis of cardiovascular adverse events associated with immune checkpoint inhibitors. Cardiooncology. 2021;7(1):19. https:\/\/doi.org\/10.1186\/s40959-021-00106-x.","journal-title":"Cardiooncology"},{"issue":"24","key":"7740_CR54","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.1161\/circulationaha.120.049981","volume":"142","author":"ZD Drobni","year":"2020","unstructured":"Drobni ZD, Alvi RM, Taron J, et al. Association between immune checkpoint inhibitors with cardiovascular events and atherosclerotic plaque. Circulation. 2020;142(24):2299\u2013311. https:\/\/doi.org\/10.1161\/circulationaha.120.049981.","journal-title":"Circulation"},{"issue":"5","key":"7740_CR55","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.1007\/s10753-023-01859-6","volume":"46","author":"X Xiong","year":"2023","unstructured":"Xiong X, Duan Z, Zhou H, et al. The increased TIGIT-Expressing CD3(+)CD56(+) cells are associated with coronary artery disease and its inflammatory environment. Inflammation. 2023;46(5):2024\u201336. https:\/\/doi.org\/10.1007\/s10753-023-01859-6.","journal-title":"Inflammation"},{"issue":"3","key":"7740_CR56","first-page":"1335","volume":"9","author":"Q Li","year":"2017","unstructured":"Li Q, Ming T, Wang Y, et al. Increased Th9 cells and IL-9 levels accelerate disease progression in experimental atherosclerosis. Am J Transl Res. 2017;9(3):1335\u201343.","journal-title":"Am J Transl Res"},{"key":"7740_CR57","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.2147\/jir.S351364","volume":"15","author":"X Xiong","year":"2022","unstructured":"Xiong X, Luo Z, Zhou H, et al. Downregulation of TIGIT expression in FOXP3+regulatory T cells in acute coronary syndrome. J Inflamm Res. 2022;15:1195\u2013207. https:\/\/doi.org\/10.2147\/jir.S351364.","journal-title":"J Inflamm Res"},{"issue":"17","key":"7740_CR58","doi-asserted-by":"publisher","first-page":"e88628","DOI":"10.1172\/jci.insight.88628","volume":"1","author":"D Golden","year":"2016","unstructured":"Golden D, Kolmakova A, Sura S, et al. Lymphocyte activation gene 3 and coronary artery disease. JCI Insight. 2016;1(17):e88628. https:\/\/doi.org\/10.1172\/jci.insight.88628.","journal-title":"JCI Insight"},{"key":"7740_CR59","doi-asserted-by":"publisher","first-page":"988582","DOI":"10.3389\/fcvm.2022.988582","volume":"9","author":"X Xiong","year":"2022","unstructured":"Xiong X, Duan Z, Zhou H, et al. The relationship between soluble lymphocyte activation gene-3 and coronary artery disease. Front Cardiovasc Med. 2022;9:988582. https:\/\/doi.org\/10.3389\/fcvm.2022.988582.","journal-title":"Front Cardiovasc Med"},{"key":"7740_CR60","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.gene.2017.05.063","volume":"626","author":"P Hassanpour","year":"2017","unstructured":"Hassanpour P, Amirfarhangi A, Hosseini-Fard SR, Yarnazari A, Najafi M. Interleukin 6 may be related to indoleamine 2,3-dioxygense function in M2 macrophages treated with small dense LDL particles. Gene. 2017;626:442\u20136. https:\/\/doi.org\/10.1016\/j.gene.2017.05.063.","journal-title":"Gene"},{"issue":"2","key":"7740_CR61","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1093\/cvr\/cvv100","volume":"106","author":"KA Polyzos","year":"2015","unstructured":"Polyzos KA, Ovchinnikova O, Berg M, et al. Inhibition of indoleamine 2,3-dioxygenase promotes vascular inflammation and increases atherosclerosis in Apoe-\/- mice. Cardiovasc Res. 2015;106(2):295\u2013302. https:\/\/doi.org\/10.1093\/cvr\/cvv100.","journal-title":"Cardiovasc Res"},{"issue":"1","key":"7740_CR62","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1186\/s12872-021-02140-0","volume":"21","author":"N Wongpraparut","year":"2021","unstructured":"Wongpraparut N, Pengchata P, Piyophirapong S, et al. Indoleamine 2,3 dioxygenase (IDO) level as a marker for significant coronary artery disease. BMC Cardiovasc Disord. 2021;21(1):353. https:\/\/doi.org\/10.1186\/s12872-021-02140-0.","journal-title":"BMC Cardiovasc Disord"}],"container-title":["Cardiovascular Drugs and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-025-07740-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10557-025-07740-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-025-07740-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T05:21:19Z","timestamp":1778649679000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10557-025-07740-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,8]]},"references-count":62,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["7740"],"URL":"https:\/\/doi.org\/10.1007\/s10557-025-07740-y","relation":{},"ISSN":["0920-3206","1573-7241"],"issn-type":[{"value":"0920-3206","type":"print"},{"value":"1573-7241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,8]]},"assertion":[{"value":"9 June 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures and declarations"}},{"value":"The authors declare no competing interests.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}